The PinPointe FootLaser device has received the US Food and Drug Administration (FDA) clearance for the treatment of nail fungus (onychomycosis), reported Mark Spier, a practitioner in Baltimore Metropolitan area for all of its podiatry needs.
The patented PinPointe FootLaser is a specially designed laser beam that goes through the nail and safely reduces the infection in the nail bed that causes onychomycosis.
Spier said that with FDA clearance of the PinPointe FootLaser, patients have a relatively painless, important new treatment option. It is often more successful than topically applied antifungal drugs, has less side effects than oral medication, and is less painful than surgical removal of the nail.
The procedure requires one or a small number of safe, quick treatments with little or no discomfort and is performed as an outpatient service with no anesthesia.
The gentle laser light beam has no effect on healthy tissue and treats only the infected area. No drugs or topical ointments are used, eliminating the total-body side effects of traditional oral medications, Spier said.